Satiogen Pharmaceuticals

Satiogen Pharmaceuticals is a specialty pharmaceutical company focused on novel targets for the treatment of type 2 diabetes. The company's metabolic mechanism therapies aim to regulate nutrient intake and postprandial blood glucose. Its products include an alternative to metformin in gliptin formulations and an over-the-counter medication to reduce weight and postprandial blood glucose, enabling doctors to treat type 2 diabetes and obesity without intervention.